| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 10/20/2004 | EP0886528B1 Use of coxiella bacteria to treat autoimmune disease |
| 10/20/2004 | EP0831860B1 Allogeneic cell therapy for cancer following allogeneic stem cell transplantation |
| 10/20/2004 | EP0658113B1 Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof |
| 10/20/2004 | CN1538849A Use of long PENTRAXIN PTX 3 for treating female infertility |
| 10/20/2004 | CN1537652A Health-care stomach pocket with gold and Chinese medicine and its manufacturing method |
| 10/20/2004 | CN1537651A Health-care heat protecter with gold, silver and Chinese medicines and its manufacturing method |
| 10/20/2004 | CN1537542A Donkey-hide gelatin syrup |
| 10/20/2004 | CN1537491A Golden health-care cushion, and its making method |
| 10/20/2004 | CN1537480A Golden health-care kneecap, and its making method |
| 10/20/2004 | CN1537456A 阿胶红糖 Gelatin brown sugar |
| 10/20/2004 | CN1171996C American pig reproduction and respiratory syndrome syndrome (PRRS) virus and its use |
| 10/20/2004 | CN1171852C Method for inactivating virus in bio-composition |
| 10/20/2004 | CN1171628C Ointment for eliminating macula and its preparation method |
| 10/20/2004 | CN1171627C Oral pill for treatment of piles |
| 10/20/2004 | CN1171626C External treatment powder for piles |
| 10/20/2004 | CN1171625C Ant-shuangshen Tongbi pill for treating rhematoid or rheumatic arthitis and ankylosing spondylitis |
| 10/20/2004 | CN1171619C Health-care food with fatigue resistance, regulating immunologic function and its preparation method |
| 10/20/2004 | CN1171618C Healthy medicinal spirit for tonifying kidney and strengthening Yang |
| 10/20/2004 | CN1171616C Composite medicine for treating femoral head necrosis |
| 10/20/2004 | CN1171611C Powder medicine for treating cerebritis |
| 10/20/2004 | CN1171607C Medicine for treating periumbilical pain |
| 10/20/2004 | CN1171605C Pain-stopping bone-penetrating ointment and its prepn. preocess |
| 10/20/2004 | CN1171602C Plaster for treating fracture, soft tissue damage and bruise and its prepn. method |
| 10/20/2004 | CN1171601C Medicine for treating nephrosis and lung disease |
| 10/20/2004 | CN1171599C Plaster for treating pain in neck, shoulder, waist and leg and its prepn process |
| 10/20/2004 | CN1171597C Composite medicine for treating burns and its prepn. method |
| 10/20/2004 | CN1171596C Exterally applied medcine powder for treating hyperosteogent in neck and waist |
| 10/20/2004 | CN1171595C Production process of obtaining non-toxic effective buthotoxin and medicine prepared by the process for treating apilepsy |
| 10/20/2004 | CN1171594C Composition containing pearl powder and ascorbic acid |
| 10/20/2004 | CN1171593C Embedded musk and its preparing process |
| 10/19/2004 | US6806259 Low molecular weight hyaluronic acid for use as a nutritional supplement to cause softening of human skin. |
| 10/19/2004 | US6806253 Therapeutic and preventive anti-bacterial vaccine complex |
| 10/19/2004 | US6806070 Use of bacterial extracts of the pseudomonadaceae family as cosmetic agents |
| 10/19/2004 | US6805879 Made with a hydrophilic polymer; microencapsulation of proteins, peptides, viruses, bacteria, cells; diagnosis kits |
| 10/19/2004 | US6805870 Paramunity inducer based on combinations of poxvirus components, process to prepare it and its use as medicament |
| 10/19/2004 | US6805869 Cellular vaccines and immunotherapeutics and methods for their preparation |
| 10/19/2004 | US6805861 Administering therapeutically effective amount of cytotoxic t lymphocytes which have different hla class i complex (or equivalent) than cells to be killed, and specifically recognize peptide portion of antigen presented on cell surface |
| 10/19/2004 | US6805860 Delivering stem cells to site of tissue repair in region damaged by myocardial disease through blood vessel leading to site by advancing catheter through vessel, occluding vessel during delivery to increase concentration of delivered cells |
| 10/17/2004 | CA2463827A1 Methods and compositions for controlled release of bioactive compounds |
| 10/14/2004 | WO2004087930A1 Adenovirus replication-competent vectors expressing trail |
| 10/14/2004 | WO2004087899A1 Method for obtaining regulating dendritic cells and t cells |
| 10/14/2004 | WO2004087898A1 Method of transplanting foreign cell into mammalian embryo |
| 10/14/2004 | WO2004087893A1 Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains |
| 10/14/2004 | WO2004087891A1 Lactobacillus fermentum strain and uses thereof |
| 10/14/2004 | WO2004087870A2 Neuronal cell lineages and methods of production thereof |
| 10/14/2004 | WO2004087860A2 Materials and methods for regulating process formation in cell culture |
| 10/14/2004 | WO2004087182A1 Active ingredient combinations of plant oils containing $g(v)3-fatty acids and plant extracts containing isoprenoids and the use thereof |
| 10/14/2004 | WO2004087178A1 A formulation comprising a bacterial strain |
| 10/14/2004 | WO2004087177A1 Process for the staining of sperm |
| 10/14/2004 | WO2004087176A1 A composition (rucd) for protecting and/or repairing dna from oxidative damages and a method thereof |
| 10/14/2004 | WO2004071416A3 Novel inhibitors of formation of advanced glycation endproducts (ages) |
| 10/14/2004 | WO2004039248A3 Repairing or replacing tissues or organs |
| 10/14/2004 | WO2004029230A3 Cells on a support matrix for tissue repair |
| 10/14/2004 | WO2004024875A8 Mammalian megakaryocyte progenitor cell |
| 10/14/2004 | WO2004021010A3 Method of diagnosing colon and gastric cancers |
| 10/14/2004 | WO2004017916A3 Cardiovascular therapy composition including transfer factor and therapeutic methods including use of the composition |
| 10/14/2004 | WO2003100018A3 A bank of stem cells for transplantation |
| 10/14/2004 | US20040204565 Use of multivalent chimeric peptide-loaded, MHC/IG molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses |
| 10/14/2004 | US20040204481 Activation of natural killer cells by adenosine A3 receptor agonists |
| 10/14/2004 | US20040204350 Disease- associated protein |
| 10/14/2004 | US20040204345 Using recombinant zinc finger proteins; use in human therapeutic applications such as cancer therapy and altering plant phenotypes, including disease resistance, fruit ripening |
| 10/14/2004 | US20040203118 Polynucleotides and polypeptides of the IFNalpha-14 gene |
| 10/14/2004 | US20040203066 Identifying modulator of progression elevated gene-3 (PEG-3) for use in treatment and prevention of antitumor/antiproliferative/antisense agents; peptide mimetic |
| 10/14/2004 | US20040202774 Encapsulating cells and tissue with biocompatible polymers; reacting such as polyethylenimine coupled to acrylamidopropyltrimethyl ammonium chloride and initiator with polyethylene glycol triacrylate macromer; protecting from biodegradation; kits |
| 10/14/2004 | US20040202722 Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof |
| 10/14/2004 | US20040202671 helminths obtained from preparatory animals raised in a specific human pathogen-free environment used to treat an excessive immune response including an aberrant/enhanced Th1 response, e.g., Crohn's disease and ulcerative colitis |
| 10/14/2004 | US20040202667 also use in the development of antimalarial drugs and antibodies directed against these Plasmodium proteins. |
| 10/14/2004 | US20040202663 Therapy for primary and metastatic cancers |
| 10/14/2004 | US20040202660 orally administering an immunoglobulin to modulate serum IgG and/or TNF- Delta levels for treatment of autoimmune disorders, potentiation of vaccination protocols, and improvement of overall health and weight gain in animals, including humans. |
| 10/14/2004 | US20040202638 plant extracts or whey extracts, excluding soybean seed extract, prevent or ameliorate aging of the skin and inhibit wrinkle formation |
| 10/14/2004 | DE10315024A1 Wirkstoffkombination aus ω3-fettsäurehaltigen Ölen mit isoprenoidhaltigen Pflanzenextrakten und deren Verwendung Active ingredient combination of ω3-fatty acid-containing oils with isoprenoidhaltigen plant extracts and their use |
| 10/14/2004 | CA2561840A1 Use of pediocin a for the amelioration of digestive functionality |
| 10/14/2004 | CA2526861A1 Lactobacillus fermentum strain and uses thereof |
| 10/14/2004 | CA2521220A1 Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains |
| 10/14/2004 | CA2521105A1 Materials and methods for regulating process formation in cell culture |
| 10/14/2004 | CA2520861A1 Method for transdifferentiation of non-pancreatic stem cells to the pancreatic pathway |
| 10/14/2004 | CA2519989A1 Process for the staining of sperm |
| 10/13/2004 | EP1466968A2 Method and apparatus for encapsulation of biologically-active substances |
| 10/13/2004 | EP1466632A1 Implantable pouch seeded with insulin-producing cells to treat diabetes |
| 10/13/2004 | EP1466628A1 DHA-pharmaceutical agent conjugates |
| 10/13/2004 | EP1466618A1 Treatment for diabetes |
| 10/13/2004 | EP1466597A1 Use of dha esters to control or prevent cardiovascular diseases |
| 10/13/2004 | EP1466529A1 Composition with heart rate reducing properties |
| 10/13/2004 | EP1466001A2 Viruses with enhanced lytic potency medikament |
| 10/13/2004 | EP1465998A2 Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy |
| 10/13/2004 | EP1465984A1 A suprabasal breast cell line with stem cell properties |
| 10/13/2004 | EP1465983A2 Endothelial stem cells, populations, methods of isolation and use thereof |
| 10/13/2004 | EP1465982A1 Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby |
| 10/13/2004 | EP1465924A2 Modulators of notch ic protease activity for use in immunotherapy |
| 10/13/2004 | EP1465866A2 Protease inhibitors of the coagulation cascade isolated from dysidea sponges |
| 10/13/2004 | EP1465664A1 Stabilized formulations of adenovirus |
| 10/13/2004 | EP1465660A2 Methods and compositions for modulating regulation of the cytotoxic lymphocyte response by macrophage migration inhibitory factor |
| 10/13/2004 | EP1465644A1 Method for obtaining an anti-tumor substance from even-toe hoofed mammals |
| 10/13/2004 | EP1465643A1 Methods and compositions for oxygen transport comprising a high oxygen affinity |
| 10/13/2004 | EP1465634A2 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation |
| 10/13/2004 | EP1465493A1 Cultured and encapsulated pancreatic stem cells |
| 10/13/2004 | EP1465489A2 Methods of expressing lim mineralization protein in non-osseous cells |
| 10/13/2004 | EP1107746B1 Methods of using and compositions comprising dopamine reuptake inhibitors |
| 10/13/2004 | EP1102858B1 Cell lines for the propagation of mutated herpes viruses |
| 10/13/2004 | EP1012291B1 Multiple site delivery of adenoviral vector for the induction of angiogenesis |